Hot-start Taq DNA Polymerase
Hot-start Taq DNA Polymerase
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- L/C,T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- enzyme, pcr, taq dna polymerase
- Category
- Other Chemicals
Rapigen Biologicals Inc
South Korea
- Verified Certificate
-
1
| Product name | Hot-start Taq DNA Polymerase | Certification | - |
|---|---|---|---|
| Category | Other Chemicals | Material | - |
| Keyword | enzyme , pcr , taq dna polymerase | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | 100 |
| Supply type | Available | HS code | 382200 |
Product Information
Description
By coupling with Anti-Taq Monoclonal Antibody, it is a Taq DNA polymerase that is activated by high-temperature treatment, so the generation of non-specific products can be minimized. Genes can be effectively amplified when the amount of template DNA is small or the template DNA has a complex structure. Because of its high amplification specificity for individual genes, it can be used for multiplex experiments and molecular diagnostic tests that simultaneously amplify multiple genes. Therefore, gene amplification results can be confirmed quickly.
Feature
Thermal Stable & Fast Fast and accurate PCR results can be confirmed due to high processivity
Specificity Minimization of non-specific amplification
Sensitivity In the case of human genomic DNA, gene amplification is possible from 16 pg of template DNA
Application
Standard PCR, Colony PCR, Fast PCR, T/A Cloning, Multiplex PCR
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | L/C,T/T | Shipping time | Negotiable |
- President
- HYE KYEONG KIM
- Address
- N106, 11-3, Techno 1-ro, , Yuseong-gu, Daejeon, Korea
- Product Category
- Chemical Reagents & Products,Other Chemicals
- Year Established
- 2018
- No. of Total Employees
- 1-50
- Company introduction
-
founded in January 2018 as a venture company, has made several attempts to develop and produce enzymes and monoclonal antibodies for molecular diagnostic kits and to raise their activities. We are aiming at developing enzymes and supplying them to research institutes or for academic researches and furthermore, world-class molecular diagnostic kits with these enzymes for the benefit of the world.
- Main Markets
-
Australia
China
India
Japan
Thailand
- Main Product
